Twice-a-Year shot could revolutionize HIV prevention for women
NCT ID NCT06101329
Summary
This study is testing a new, long-acting injection called lenacapavir, given just twice a year, to see if it can safely prevent HIV infection in women in the United States. It will compare this injection to a standard daily pill. The main goals are to see how the drug moves through the body, check for side effects, and find out if women find the injection acceptable and easy to use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cornell Clinical Trials Unit, New York Presbyterian Hospital - Weill Cornell Medicine
New York, New York, 10010, United States
-
Fenway Health
Boston, Massachusetts, 02215, United States
-
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
-
Harlem Prevention Center CRS
New York, New York, 10027, United States
-
ICAP at Columbia University - Bronx Prevention Center
The Bronx, New York, 10451, United States
-
NC TraCS Institute - CTRC; University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
Penn Prevention Research Unit
Philadelphia, Pennsylvania, 19104, United States
-
Ponce de Leon Center Clinical Research Site
Atlanta, Georgia, 30303, United States
-
Rutgers New Jesey Medical School - Clinical Research Center
Newark, New Jersey, 07103, United States
-
UAB, 1917 Research Clinic
Birmingham, Alabama, 35222, United States
-
UCSD Antiviral Research Center (AVRC)
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.